RESUMO
The aim of this study was to evaluate the prevalence of concomitant idiopathic cyclic edema with Grade II and III cellulite. All patients treated for Grade II and III cellulite were evaluated for idiopathic cyclic edema in a retrospective, quantitative and cross-sectional study. The study was carried out at the Godoy Clinic in the period from 2006 to 2010. All patients with body mass indexes > 25, Grade I cellulite and other causes of edema were excluded. The diagnosis of idiopathic cyclic edema was based on a clinical history and fluid retention throughout the day, in particular difficulty in removing rings on waking in the morning which improves later in the day. All patients with cyclic edema were treated with 75 mg aminaphtone three times daily. Statistical analysis considered the frequency of edema. Of the 82 women evaluated with ages between 18 and 58 years old (mean of 34.9 years) 41 (50.0%) were diagnosed with idiopathic cyclic edema. Idiopathic cyclic edema is an aggravating factor for cellulite and is frequently associated with the more advanced stages of the disease. Its control is essential in the treatment of cellulite.
Assuntos
Tecido Adiposo/patologia , Edema/diagnóstico , Ácido 4-Aminobenzoico/uso terapêutico , Adolescente , Adulto , Estudos Transversais , Edema/tratamento farmacológico , Feminino , Hemostáticos/uso terapêutico , Humanos , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem , para-AminobenzoatosRESUMO
La queilitis actínica crónica es una reconocida lesión precancerosa del labio en áreas expuestas al sol. Se detallan las características de riesgo de los pacientes y los aspectos clínicos e histológicos. Se presenta un caso con el fin de señalar los procedimientos diagnósticos y terapéuticos empleados y la conducta de seguimiento
Assuntos
Humanos , Masculino , Idoso , Queilite/terapia , Ácido 4-Aminobenzoico/uso terapêutico , Protetores Solares/uso terapêutico , Raios Ultravioleta/efeitos adversosRESUMO
La queilitis actínica crónica es una reconocida lesión precancerosa del labio en áreas expuestas al sol. Se detallan las características de riesgo de los pacientes y los aspectos clínicos e histológicos. Se presenta un caso con el fin de señalar los procedimientos diagnósticos y terapéuticos empleados y la conducta de seguimiento (AU)
Assuntos
Humanos , Masculino , Idoso , Queilite/terapia , Raios Ultravioleta/efeitos adversos , Ácido 4-Aminobenzoico/uso terapêutico , Protetores Solares/uso terapêuticoRESUMO
Se describe un caso de Enfermedad de Peyronie en un paciente hipertenso tratado en forma crónica con nadolol (betabloqueante). Se establece la asociación hoy descrita entre esta enfermedad y este tipo de drogas, señalandose que este efecto secundario, aunque raro, debe tomarse en cuenta en pacientes hipertensos que reciben betabloqueantes
Assuntos
Adulto , Humanos , Masculino , Hipertensão/tratamento farmacológico , Induração Peniana/radioterapia , Nadolol/uso terapêutico , Ácido 4-Aminobenzoico/uso terapêuticoRESUMO
65 pregnant women distributed in two groups, by a double-blind method received a placebo or a sunscreen cream (Pabafil SPF 10, with absorption range from 290 to 360 nm) for daily use on face during the second quarter of their pregnancy in summer time. In 30 patients "with optimum fulfillment" in the products application (16 with placebo and 14 with sunscreen cream) the melasma appearances were significantly lower in those with sunscreen application. In subgroups of the total number of pregnant women, with similar proportion of patients with placebo and sunscreen, the melasma appearances were significantly lower in skin types I-II, and in those that used cosmetics (versus those that did not). No differences were observed in subgroups by age, parity, and with or without history of previous melasma.
Assuntos
Ácido 4-Aminobenzoico/uso terapêutico , Aminobenzoatos/uso terapêutico , Melanose/prevenção & controle , Complicações na Gravidez/prevenção & controle , Protetores Solares/uso terapêutico , Adolescente , Adulto , Feminino , Humanos , Fenóis/uso terapêutico , Gravidez , Distribuição Aleatória , para-AminobenzoatosRESUMO
Foram tratados 40 pacientes idosos acometidos por síndrome varicosa crônica com aminaftona, com dose diária de 225 mg, durante 75 dias. No final do tratamento foi evidenciada uma nítida melhora dos vários parâmetros subjetivos e objetivos tomados em consideraçäo, juntamente a uma perfeita tolerância do medicamento